The Valley Desk

NCT02807285 · Expanded access

Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

Overall registry status No longer available

Conditions Multiple Sclerosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov